Advertisement

Topics

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc. Company Profile

05:10 EST 18th January 2018 | BioPortfolio

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded drug products and develops new medicines to treat patients suffering from diseases principally in five therapeutic areas: central nervous system, cardiovascular, gastrointestinal, respiratory, and anti-infective. Forest’s strategy of acquiring product rights for development and commercialization through licensing, collaborative partnerships and targeted mergers and acquisitions allows Forest to take advantage of attractive late-stage development and commercial opportunities, thereby managing the risks inherent in drug development. In January 2014, Forest acquired Aptalis Pharmaceuticals for $2.9 billion in cash in order to gain access to its GI and Cystic Fibrosis products, including treatments for Ulcerative Proctitis, Duodenal Ulcers, H. Pylori, Anal Fissures, and Pancreatic Insufficiency. In February 2014, Forest and Actavis plc announced an agreement where Forest would be acquired for about $25 billion in cash and stock. The acquisition of Forest by Actavis is contingent upon regulatory and shareholder approvals.


News Articles [991 Associated News Articles listed on BioPortfolio]

Forest Blow, PTV News: Apr 08, 2010

FDA panel says no to Forest Laboratories' lung drug Daxas

Creation of forest edges has a global impact on forest vertebrates

Fragmentation of forest ecosystems produces forest edges, which affect the distribution of many analysed vertebrate species; smaller-bodied amphibians, larger reptiles and medium-sized mammals experie...

Hiding from a warmer climate in the forest

(Stockholm University) Global warming threatens forest plants adapted to cooler temperatures. An international team of scientists from the universities of Stockholm, Marseille and Helsinki have unrave...

MSU environmental scientist wins grant to research forest management consequences

(Montana State University) William Kleindl and colleagues will use a $312,000 grant from the National Science Foundation to determine what effect forest management decisions have on forest ecology fro...

Initial survey results reveal a worrying decline in Guinea's forest elephant population

A new survey by Fauna & Flora International (FFI) has highlighted the increasing risk in the density and distribution of forest elephants in Guinea's Ziama Massif forest. This is the first time that s...

Forestry: Sustainability crisis brews in EU forestry

The European Parliament decided in September that member states of the European Union can increase forest harvesting, provided the forest's carbon sink remains positive and sustainable forest-manageme...

$900K NSF grant helps Wake Forest researchers look for the big picture in big data

(Wake Forest University) Thanks to a $900,000 award from the National Science Foundation, Wake Forest University researchers are examining how the plant hormone ethylene affects growth and development...

A decade of monitoring shows the dynamics of a conserved Atlantic tropical forest

(Pensoft Publishers) Characterized with high levels of biodiversity and endemism, the Atlantic Tropical Forest has been facing serious anthropogenic threats over the last several decades. Having put i...

PubMed Articles [662 Associated PubMed Articles listed on BioPortfolio]

Laboratory- and full-scale studies on the removal of pharmaceuticals in an aerated constructed wetland: effects of aeration and hydraulic retention time on the removal efficiency and assessment of the aquatic risk.

Pharmaceutical residues in wastewater pose a challenge to wastewater treatment technologies. Constructed wetlands (CWs) are common wastewater treatment systems in rural areas and they discharge often ...

Inconsistent estimates of forest cover change in China between 2000 and 2013 from multiple datasets: differences in parameters, spatial resolution, and definitions.

The Chinese National Forest Inventory (NFI) has reported increased forest coverage in China since 2000, however, the new satellite-based dataset Global Forest Change (GFC) finds decreased forest cover...

Sustainability assessment in forest management based on individual preferences.

This paper presents a methodology to elicit the preferences of any individual in the assessment of sustainable forest management at the stand level. The elicitation procedure was based on the comparis...

Responses of LAI to rainfall explain contrasting sensitivities to carbon uptake between forest and non-forest ecosystems in Australia.

Non-forest ecosystems (predominant in semi-arid and arid regions) contribute significantly to the increasing trend and interannual variation of land carbon uptake over the last three decades, yet the ...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Clinical Trials [439 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [2296 Associated Companies listed on BioPortfolio]

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products so...

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive...

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by adva...

Furiex Pharmaceuticals

More Information about "Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Corporate Database Quicklinks



Searches Linking to this Company Record

Ad Here